Table 1.
Summary of the histopathological type of endometrial lesion, number of patients in each group, and mean ± SD, 95% confident limits of mean, quartiles Q1, Q2, Q3, minimal and maximal values of AMHRII expression.
| Histopathological Type of Endometrial Lesion | Patients Number | Mean ± SD | 95% C.l. | Q1–Q2–Q3 | Min–Max | |
|---|---|---|---|---|---|---|
| precancerous state (PCS) | Nonatypical endometrial hyperplasia (NH) | 8 | 5.33 ± 1.782 | 3.84–6.82 | 4.0–4.33–7.0 | 4.00–8.00 |
| Atypical hyperplasia (AH) | 4 | 6.33 ± 2.000 | 3.15–9.52 | 4.67–6.67–8.0 | 4.00–8.00 | |
| type 1 according Bokhman’s | Endometrioid adenocarcinoma G1 (G1) | 49 | 5.69 ± 1.645 | 5.21–6.16 | 4.0–5.33–7.33 | 2.67–8.00 |
| Endometrioid adenocarcinoma G2 (G2) | 146 | 6.32 ± 1.801 | 6.03–6.62 | 4.67–6.67–8.0 | 2.33–12.00 | |
| Endometrioid adenocarcinoma G3 (G3) | 6 | 6.44 ± 1.559 | 4.81–8.08 | 4.67–6.67–8.0 | 4.67–8.00 | |
| type 2 according Bokhman’s | Serous adenocarcinoma (SA) | 8 | 6.25 ± 1.591 | 4.92–7.58 | 4.0–4.33–7.0 | 4.00–8.00 |
| Clear cell adenocarcinoma (CCA) | 4 | 6.83 ± 1.575 | 4.33–9.34 | 5.67–7.33–8.0 | 4.67–8.00 | |
| Mixed adenocarcinoma (MA) | 5 | 7.60 ± 0.894 | 6.49–8.71 | 8.0–8.0–8.0 | 6.00–8.00 | |